biowizard.com
17-Aug-2008
1Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut, USA. Bisphosphonates are valuable agents for the treatment of post-menopausal osteoporosis (PMO), hypercalcemia of malignancy, and osteolytic...